Named Patient Program for Mitomycin for Pyelocalyceal Solution

Summary

This program provides controlled, pre-approval access to JELMYTO in response to unsolicited requests by physicians, hospitals, pharmacies, distributors, ministries of health or other parties on behalf of specific, or named patients, in select countries where JELMYTO has not yet received a marketing authorization and in situations when patients have exhausted all available treatment options.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications